181 related articles for article (PubMed ID: 30235109)
1. Pharmacogenetics of Antiretroviral Drug Response and Pharmacokinetic Variations in Indigenous South African Populations.
O'Connell KS; Swart M; McGregor NW; Dandara C; Warnich L
OMICS; 2018 Sep; 22(9):589-597. PubMed ID: 30235109
[TBL] [Abstract][Full Text] [Related]
2. Organic Cation Transporter 2 (OCT2/SLC22A2) Gene Variation in the South African Bantu-Speaking Population and Functional Promoter Variants.
Wilson NC; Choudhury A; Carstens N; Mavri-Damelin D
OMICS; 2017 Mar; 21(3):169-176. PubMed ID: 28253084
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Certain Pharmacogenetic Differences on the Metabolism of Antiretroviral Drugs Used in A Black South African Population.
Reay R; Viljoen M; Rheeders M
Curr Drug Metab; 2023; 24(10):700-708. PubMed ID: 38008947
[TBL] [Abstract][Full Text] [Related]
4. Characterization of
Booyse RP; Twesigomwe D; Hazelhurst S
Pharmacogenomics; 2022 Sep; 23(14):771-782. PubMed ID: 36043428
[No Abstract] [Full Text] [Related]
5. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.
Dandara C; Lombard Z; Du Plooy I; McLellan T; Norris SA; Ramsay M
Pharmacogenomics; 2011 Dec; 12(12):1663-70. PubMed ID: 22118051
[TBL] [Abstract][Full Text] [Related]
7. High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.
Swart M; Skelton M; Ren Y; Smith P; Takuva S; Dandara C
Pharmacogenet Genomics; 2013 Aug; 23(8):415-27. PubMed ID: 23778320
[TBL] [Abstract][Full Text] [Related]
8. Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.
Li J; Lao X; Zhang C; Tian L; Lu D; Xu S
BMC Genet; 2014 May; 15():52. PubMed ID: 24884825
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.
Tekola-Ayele F; Adeyemo A; Aseffa A; Hailu E; Finan C; Davey G; Rotimi CN; Newport MJ
Pharmacogenomics J; 2015 Feb; 15(1):101-108. PubMed ID: 25069476
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
Sinxadi PZ; Leger PD; McIlleron HM; Smith PJ; Dave JA; Levitt NS; Maartens G; Haas DW
Br J Clin Pharmacol; 2015 Jul; 80(1):146-56. PubMed ID: 25611810
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations.
Twesigomwe D; Drögemöller BI; Wright GEB; Adebamowo C; Agongo G; Boua PR; Matshaba M; Paximadis M; Ramsay M; Simo G; Simuunza MC; Tiemessen CT; Lombard Z; Hazelhurst S
Clin Pharmacol Ther; 2024 Mar; 115(3):576-594. PubMed ID: 38049200
[TBL] [Abstract][Full Text] [Related]
12. The genomic landscape of African populations in health and disease.
Rotimi CN; Bentley AR; Doumatey AP; Chen G; Shriner D; Adeyemo A
Hum Mol Genet; 2017 Oct; 26(R2):R225-R236. PubMed ID: 28977439
[TBL] [Abstract][Full Text] [Related]
13. The global spectrum of protein-coding pharmacogenomic diversity.
Wright GEB; Carleton B; Hayden MR; Ross CJD
Pharmacogenomics J; 2018 Jan; 18(1):187-195. PubMed ID: 27779249
[TBL] [Abstract][Full Text] [Related]
14. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future.
Ndadza A; Thomford NE; Mukanganyama S; Wonkam A; Ntsekhe M; Dandara C
OMICS; 2019 Mar; 23(3):152-166. PubMed ID: 30883300
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 pharmacogenetics in African populations.
Alessandrini M; Asfaha S; Dodgen TM; Warnich L; Pepper MS
Drug Metab Rev; 2013 May; 45(2):253-75. PubMed ID: 23590174
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa.
Baker JL; Shriner D; Bentley AR; Rotimi CN
Pharmacogenomics J; 2017 Mar; 17(2):112-120. PubMed ID: 27779243
[TBL] [Abstract][Full Text] [Related]
17. Warfarin Dose and CYP2C Gene Cluster: An African Ancestral-Specific Variant Is a Strong Predictor of Dose in Black South African Patients.
Ndadza A; Cindi Z; Makambwa E; Chimusa E; Wonkam A; Kengne AP; Ntsekhe M; Dandara C
OMICS; 2019 Jan; 23(1):36-44. PubMed ID: 30566377
[TBL] [Abstract][Full Text] [Related]
18. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.
Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C
OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284
[TBL] [Abstract][Full Text] [Related]
19. CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study.
Reay R; Dandara C; Viljoen M; Rheeders M
OMICS; 2017 Aug; 21(8):465-473. PubMed ID: 28816644
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population.
Wright GE; Niehaus DJ; Drögemöller BI; Koen L; Gaedigk A; Warnich L
Ann Hum Genet; 2010 Jul; 74(4):340-50. PubMed ID: 20597905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
